These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G. J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038 [Abstract] [Full Text] [Related]
28. Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole. Rath PM. J Antimicrob Chemother; 1998 May; 41(5):567-70. PubMed ID: 9630411 [Abstract] [Full Text] [Related]
29. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro]. Xu Y, Pang GR, Lü XF, Chen ZJ, Sun ST, Song JZ. Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206 [Abstract] [Full Text] [Related]
30. Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study. Tortorano AM, Dannaoui E, Meletiadis J, Mallie M, Viviani MA, Piens MA, Rigoni AL, Bastide JM, Grillot R, EBGA Network. European Group for Research on Biotypes and Genotypes of Aspergillus fumigatus. J Chemother; 2002 Jun; 14(3):246-52. PubMed ID: 12120878 [Abstract] [Full Text] [Related]
31. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. Johnson EM, Szekely A, Warnock DW. J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897 [Abstract] [Full Text] [Related]
32. In vitro interactions between antifungals and methotrexate against Aspergillus spp. Yang J, Wan Z, Wang X, Liu W, Li R. Mycopathologia; 2009 Nov; 168(5):237-42. PubMed ID: 19548112 [Abstract] [Full Text] [Related]
33. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects. Vitale RG, De Hoog GS, Verweij PE. Med Mycol; 2003 Aug; 41(4):301-7. PubMed ID: 12964723 [Abstract] [Full Text] [Related]
34. In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds. Biancalana FS, Lyra L, Schreiber AZ. Antimicrob Agents Chemother; 2011 Sep; 55(9):4485-7. PubMed ID: 21690288 [Abstract] [Full Text] [Related]
36. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey. Yenişehirli G, Tunçoğlu E, Yenişehirli A, Bulut Y. Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487 [Abstract] [Full Text] [Related]
37. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms. Kohler LM, Soares BM, de Assis Santos D, Da Silva Barros ME, Hamdan JS. Can J Microbiol; 2006 Sep; 52(9):843-7. PubMed ID: 17110976 [Abstract] [Full Text] [Related]
38. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus. Guinea J, Peláez T, Alcalá L, Bouza E. Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455 [Abstract] [Full Text] [Related]
39. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Lewis RE, Wiederhold NP, Klepser ME. Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887 [Abstract] [Full Text] [Related]
40. In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi. McGinnis MR, Pasarell L. Med Mycol; 1998 Aug; 36(4):243-6. PubMed ID: 9776842 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]